Three-Year Clinical Outcome of Patients Treated With the Nobori Biolimus-Eluting Stent and Xience/Promus Cobalt-Chromium Everolimus-Eluting Stent for Unprotected Left Main Disease

被引：0
|
作者：
Hiromasa, Takashi
Kuramitsu, Shoichi
Jinnouchi, Hiroyuki
Morinaga, Takashi
Kobayashi, Yohei
Domei, Takenori
Hyodo, Makoto
Soga, Yoshimitsu
Shirai, Shinichi
Ando, Kenji
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Drug eluting stents; Coronary interventions;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15516
引用
收藏
页数：6
相关论文
共 21 条
  • [1] Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent Trial
    Natsuaki, Masahiro
    Kozuma, Ken
    Morimoto, Takeshi
    Kadota, Kazushige
    Muramatsu, Toshiya
    Nakagawa, Yoshihisa
    Akasaka, Takashi
    Igarashi, Keiichi
    Tanabe, Kengo
    Morino, Yoshihiro
    Ishikawa, Tetsuya
    Nishikawa, Hideo
    Awata, Masaki
    Abe, Mitsuru
    Okada, Hisayuki
    Takatsu, Yoshiki
    Ogata, Nobuhiko
    Kimura, Kazuo
    Urasawa, Kazushi
    Tarutani, Yasuhiro
    Shiode, Nobuo
    Kimura, Takeshi
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (10)
  • [2] One-Year Clinical Outcomes With Biodegradable Polymer Biolimus-Eluting Stent in Patients With Diabetes Mellitus: Comparison With Durable Polymer Everolimus-Eluting Stent
    Morinaga, Takashi
    Kuramitsu, Shoichi
    Goya, Kaoru
    Oe, Kensuke
    Hiromasa, Takashi
    Kobayashi, Yohei
    Ando, Kenji
    Yokoi, Hiroyoshi
    Iwabuchi, Masashi
    CIRCULATION, 2013, 128 (22)
  • [3] Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction
    Yu, HyeYon
    Ahn, Jihun
    Choi, Byoung Geol
    Park, Soohyung
    Kang, Dong Oh
    Choi, Cheol Ung
    Rha, Seung-Woon
    Jeong, Myung Ho
    TEXAS HEART INSTITUTE JOURNAL, 2024, 51 (01)
  • [4] Clinical and Angiographic Outcomes of Patients Treated With Everolimus-Eluting Stents or First-Generation Paclitaxel-Eluting Stents for Unprotected Left Main Disease
    Valenti, Renato
    Migliorini, Angela
    Parodi, Guido
    Carrabba, Nazario
    Vergara, Ruben
    Dovellini, Emilio V.
    Antoniucci, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (14) : 1217 - 1222
  • [5] SYNTAX Score and SYNTAX Score II Can Predict the Clinical Outcomes of Patients with Left Main and/or 3-Vessel Disease Undergoing Percutaneous Coronary Intervention in the Contemporary Cobalt-Chromium Everolimus-Eluting Stent Era
    Kang, Jeehoon
    Han, Jung-Kyu
    Kang, Do-Yoon
    Zheng, Chengbin
    Yang, Han-Mo
    Park, Kyung-Woo
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Kim, Hyo-Soo
    KOREAN CIRCULATION JOURNAL, 2020, 50 (01) : 22 - 34
  • [6] One-year outcome of the everolimus-eluting, balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patients
    Taeymans, Kim
    Bosiers, Marc
    Deloose, Koen
    Callaert, Joren
    Keirse, Koen
    Verbist, Jurgen
    van den Eynde, Wouter
    Torsello, Giovanni
    Wauters, Jeroen
    JOURNAL OF CARDIOVASCULAR SURGERY, 2020, 61 (04) : 445 - 450
  • [7] Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study
    Kerkmeijer, Laura S. M.
    Tijssen, Ruben Y. G.
    Hofma, Sjoerd H.
    van Der Schaaf, Rene J.
    Arkenbout, E. Karin
    Weevers, Auke P. J. D.
    Kraak, Robin P.
    Onuma, Yoshinobu
    Serruys, Patrick W.
    Piek, Jan J.
    Tijssen, Jan G. P.
    Henriques, Jose P. S.
    de Winter, Robbert J.
    Wykrzykowska, Joanna J.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 98 (04) : 713 - 720
  • [8] Long-Term Vascular Response to Cobalt-Chromium Everolimus-Eluting Stent: Five-Year Follow-Up Optical Coherence Tomography Study
    Kuramitsu, Shoichi
    Sonoda, Shinjo
    Jinnouchi, Hiroyuki
    Muraoka, Yoshitaka
    Shirai, Shinichi
    Ando, Kenji
    CIRCULATION, 2016, 134
  • [9] One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study
    Thomas, Martyn R.
    Birkemeyer, Ralf
    Schwimmbeck, Peter
    Legrand, Victor
    Moreno, Raul
    Briguori, Carlo
    Werner, Nikos
    Bramucci, Ezio
    Ungi, Imre
    Richardt, Gert
    Underwood, Paul L.
    Dawkins, Keith D.
    EUROINTERVENTION, 2015, 10 (11) : 1267 - 1271
  • [10] 5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents Final Results From the SPIRIT III Trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)
    Gada, Hemal
    Kirtane, Ajay J.
    Newman, William
    Sanz, Mark
    Hermiller, James B.
    Mahaffey, Kenneth W.
    Cutlip, Donald E.
    Sudhir, Krishnankutty
    Hou, Liming
    Koo, Kai
    Stone, Gregg W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (12) : 1263 - 1266
123